IMPULSE(SZ:002899) Xin Lang Cai Jing·2026-01-09 05:55Core Viewpoint - The stock of Qingdao Inpace Health Technology Co., Ltd. has shown a positive trend with a 6.28% increase in price year-to-date, reflecting a strong performance in the fitness equipment sector despite a decline in revenue and net profit for the year [1][2]. Group 1: Stock Performance - As of January 9, Inpace's stock price increased by 2.03%, reaching 29.09 CNY per share, with a total market capitalization of 4.299 billion CNY [1]. - The stock has experienced a year-to-date increase of 6.28%, with a 10.44% rise over the past 20 days and a 19.96% increase over the past 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Inpace reported a revenue of 856 million CNY, a year-on-year decrease of 4.53%, and a net profit attributable to shareholders of 50.75 million CNY, down 41.88% compared to the previous year [2]. - Cumulatively, Inpace has distributed 56.19 million CNY in dividends since its A-share listing, with 28.95 million CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Inpace decreased by 24.69% to 14,800, while the average number of circulating shares per person increased by 32.78% to 10,016 shares [2]. - Notable institutional shareholders include Minsheng Jia Yin Continuous Growth Mixed Fund, which is the sixth-largest shareholder with 1.3563 million shares, and Huaxia Stable Growth Mixed Fund, which increased its holdings by 116,000 shares [3].